The Latest: US weighs next steps for J&J coronavirus shot

Wednesday, April 14, 2021 | The Associated Press


In this March 3, 2021, file photo, Johnson & Johnson COVID-19 vaccine is held by pharmacist Madeline Acquilano at Hartford Hospital in Hartford, Conn. U.S. health officials are weighing next steps as they investigate unusual blood clots in a small number of people given the vaccine -- a one-dose shot that many countries hoped would help speed protection against the pandemic. (AP Photo/Jessica Hill, File)

NEW YORK — U.S. health officials are weighing next steps as they investigate a handful of unusual blood clots in women who received Johnson & Johnson’s COVID-19 vaccine.

The reports are exceedingly rare — so far, six cases out of more than 7 million inoculations. And it’s not clear if they are linked to the J&J vaccine.

European regulators have declared such blood clots a rare but possible risk with the similarly made AstraZeneca vaccine. The Centers for Disease Control and Prevention in the U.S. will debate in a public meeting Wednesday how to handle the J&J vaccine while authorities investigate.

“Right now, we believe these events to be extremely rare, but we are also not yet certain we have heard about all possible cases as this syndrome may not be easily recognized,” says CDC Director Rochelle Walensky before the meeting.

___

THE VIRUS OUTBREAK:

— US weighs next steps for J&J virus shot amid clot mystery

— EU plans Pfizer vaccine contract extension to 2023

— South Africans concerned about pause in use of J&J vaccines

— Postponed Tokyo Olympics is scheduled to open in 100 days

— Follow AP’s pandemic coverage at https://apnews.com/hub/coronavirus-pandemic and https://apnews.com/hub/coronavirus-vaccine

___

HERE’S WHAT ELSE IS HAPPENING:

JOHANNESBURG — South Africa’s decision to suspend the use of the Johnson & Johnson vaccine due to preliminary reports of rare blood clots has left the country without any shots.

That comes as it struggles to combat an aggressive coronavirus variant. South Africa’s more than 1.5 million confirmed coronavirus cases represent more than 30% of all the confirmed cases in Africa.

It has only inoculated 290,00 health care workers so far, all with the Johnson & Johnson vaccine. South Africa’s plans to begin large-scale vaccinations next month are dependent upon deliveries of the Johnson & Johnson and the Pfizer vaccines.

Some health experts criticized South Africa’s move to pause the Johnson & Johnson product at such a critical juncture.

___

REIMS, France — French President Emmanuel Macron has announced free psychological counseling will be provided to children and teenagers having mental health difficulties because of the coronavirus pandemic. Those ages 3 to 17 will be entitled to 10 free sessions with a psychologist, with a doctor’s prescription.

Macron announced the additional help after meeting doctors and families at a pediatric psychiatric unit. His office says the plan will run for the duration of the pandemic.

Doctors have reported surges of psychiatric emergencies involving young people, including attempted suicides, panic attacks and other symptoms of mental anguish.

___

MILAN — Italy is set to receive an additional 7 million doses of the Pfizer vaccine by the end of June.

“Finally, a bit of good news,” the commissioner for Italy’s COVID emergency, Franceso Paolo Figliuolo, says Wednesday from the tiny northern region of Aosta.

He says the additions were the result of an increase in arrivals to Europe of 50 million Pfizer doses. It is the third boost in doses of the Pfizer vaccine ordered by Italy, which already was set to receive some 25 million doses by the end of June.

Italy has put on hold the Johnson & Johnson vaccine, following the warning from the U.S. Food and Drug Administration. First J&J deliveries arrived on Tuesday and were set to reach 7.3 million by the end of the quarter.

___

LONDON — European countries are diverging on whether to push ahead with giving residents Johnson & Johnson’s COVID-19 vaccine after reports of rare blood clots in a handful of recipients in the United States. Some leaders opted for caution Wednesday after U.S. officials paused the vaccine’s use while they study the clots in a handful of people.

Italy, the Netherlands, Croatia and Denmark put their Johnson & Johnson lots in storage while waiting for guidance from European health officials. But Poland and France said they would administer the doses they received.

Experts agree COVID-19 poses a much larger risk of hospitalization and death than the potential threat of atypical clots.

The AstraZeneca vaccine is in wide use around the globe, though not yet in the U.S. Several countries have imposed age restrictions on its use because of blood clot concerns. Denmark, which put the vaccine on hold last month, decided Wednesday not to resume using the shots it had on hand. It will offer a second dose of a different vaccine if citizens had received a first dose of AstraZeneca.

___

SAN JUAN, Puerto Rico — The government of Trinidad and Tobago says it is closing all beaches in the twin-island nation for three weeks to stem a rise in coronavirus cases.

Officials also say they’re banning indoor dining at restaurants, bars and casinos. Only groups of five, instead of 10, will be allowed to gather in public. The measures take effect at midnight Thursday.

Trinidad and Tobago had previously canceled one of the biggest carnival celebrations in the Caribbean for this year.

The nation of 1.2 million people has reported more than 8,500 cases and more than 140 confirmed deaths. Among those who have tested positive for coronavirus is Prime Minister Keith Rowley. More than 10,000 people have been vaccinated so far.

___

LONDON — The European Medicines Agency is assessing the rare blood clots reported in the U.S. after receiving the Johnson & Johnson COVID-19 vaccine, and a recommendation for European countries is expected soon.

“EMA is expediting this evaluation and currently expects to issue a recommendation next week,” the EMA says. The agency authorized the J&J shot for use across the 27-bloc EU last month, although no countries had started widespread vaccination campaigns with it.

“EMA remains of the view that the benefits of the vaccine in preventing COVID-19 outweigh the risks of side effects.”

The EU drug regulator says it was investigating the six cases reported among nearly 7 million people vaccinated with the single-dose J&J shot. The EMA says it was in contact with officials at the U.S. Food and Drug Administration and the Centers for Disease Control and Prevention about their ongoing probe.

The rare blood clots, in combination with a low level of blood platelets, caused American officials to pause the vaccine while they investigate.

___

MADISON, Wis. — The Wisconsin Supreme Court says Gov. Tony Evers’ administration doesn’t have the authority to issue capacity limits on bars, restaurants and other businesses without approval of the Legislature.

The ruling comes two weeks after the conservative-controlled court struck down the state’s mask mandate.

The Supreme Court also ruled last year in a similar case, saying the Democratic governor needed legislative approval for an emergency declaration that shut down businesses early in the coronavirus pandemic.

There hasn’t been a statewide capacity limit restriction in place since October.

The Supreme Court ruled 4-3 on Wednesday the order issued by Evers’ Department of Health Services meets the definition of a rule, which by law must go through the Republican-controlled Legislature. The court’s four conservative justices ruled against Evers, while three liberals dissented.

___

HELSINKI — Health officials in Finland announced the country will keep using the AstraZeneca vaccine and only administer it to people age 65 and over as it has done since late March.

Finland temporarily suspended the AstraZeneca vaccine for more than a week on March 19 after brain blood clots were diagnosed in two individuals who had received the jab. It continued administering it later the same month to people 65 and over.

“They have not been found to have an increased risk of developing very rare blood clotting problems after vaccination,” said Chief Physician Hanna Nohyek at the Finnish National Institute for Health and Welfare.

Three blood clot cases have been reported in Finland, a nation of 5.5 million, with the nearly 250,000 people receiving the shot by AstraZeneca.

All three cases were diagnosed in patients under 65, health officials say.

___

BRUSSELS — The head of the European Union’s executive arm has announced plans for a major contract extension for COVID-19 vaccines with Pfizer stretching to 2023.

European Commission President Ursula von der Leyen said Wednesday that the EU will start negotiating to buy 1.8 billion doses of the Pfizer vaccine through 2023. Pfizer has been a mainstay of the EU’s vaccination drive so far.

Von der Leyen expressed full confidence in the technology used for the Pfizer vaccine, which is different from the technology behind the AstraZeneca vaccine.

Pfizer plans to provide the EU with an extra 50 million doses in the second quarter of this year, on top of 200 million doses already earmarked for the bloc. The deliveries will be especially welcomed by the EU’s 27 member nations considering supply delays and concerns about rare blood clots potentially linked to the AstraZeneca vaccine.

___

MOSCOW — Russian President Vladimir Putin says he has gotten his second COVID-19 vaccine shot, three weeks after getting the first dose.

The Russian leader announced getting the jab, which was kept out of the public eye, at a session of the Russian Geographical Society on Wednesday, in which he took part via video link.

“Right now, before entering this hall, I have also gotten the second jab. I hope everything will be fine. I don’t even hope as much as I’m sure of it,” Putin said.

Putin got his first coronavirus shot on March 23, also out of sight of the cameras, and the Kremlin wouldn’t reveal which of the three vaccines currently approved for use in Russia the president has taken.

The Russian leader’s vaccination comes several months after widespread immunization against COVID-19 started in Russia — a delay that puzzled many, with some critics arguing that it was contributing to the already existing public hesitancy about the vaccine.

Russian authorities have given regulatory approval to three domestically developed shots — Sputnik V, EpiVacCorona and CoviVac. All three received authorization before completing advanced trials experts say are necessary to ensure their safety and effectiveness in line with established scientific protocol.

___

BANGKOK — Thailand reported more than 1,300 new COVID-19 infections on Wednesday, setting another daily record.

It adds pressure on the government to speed up a nearly nonexistent vaccination drive and do more to control a surge that comes amid mass travel as the country celebrates its traditional New Year festival.

The 1,335 new infections brings the number of new cases to nearly 7,000 since April 1, when a cluster was linked to nightclubs and bars in central Bangkok. Most of the new cases reported Wednesday were yet again in Bangkok. There were also large increases in the northern province of Chiang Mai and the southern seaside province of Prachuap Khiri Khan.

Many of the new infections are a more contagious variant of the virus first found in Britain. Coupled with widespread travel for the Songkran festival, or Thai New Year, that is fueling the surge, said Dr. Opas Karnkavinpong, director-general of the Disease Control Department. The festival officially began Tuesday and lasts for three days, but many people travel for a week.

___

BUCHAREST, Romania — Romania’s prime minister fired the country’s health minister Wednesday, after a series of incidents related to the COVID-19 pandemic created tensions within the governing coalition.

The move came a day after Health Minister Vlad Voiculescu reportedly made changes to the criteria the government uses to determine which virus-control restrictions to impose on local areas without informing Prime Minister Florin Citu.

Citu said the leader of USR-PLUS political alliance, Dan Barna, will serve as interim health minister.

Voiculescu was appointed in December and briefly served as Romania’s health minister in 2016. He had promised to reform the nation’s strapped health care system.

“Voiculescu meant well and insured the ministry at a critical moment in time, but it’s hard to reform an ailing system in a few months, not to mention with COVID-19 at full speed,” Radu Magdin, a Bucharest-based analyst, told The Associated Press.

___

WARSAW, Poland – Poland plans to go ahead with immunizations using the Johnson & Johnson vaccine after receiving its first batch of 120,000 doses on Wednesday.

Health Minister Adam Niedzielski said Poland is following the latest recommendations from the European Medicines Agency, which said it is “currently not clear” whether the J&J shot caused rare blood clots reported in some recipients. The EMA approved the vaccine for use in the European Union last month.

“In line with these recommendations, we will want to use it in inoculations,” Niedzielski said.

The Food and Drug Administration on Tuesday temporarily paused Johnson & Johnson shots in the United States to investigate possible links to blood clots in six women six to 13 days after vaccination.

Poland is trying to speed up its vaccination drive amid high numbers of daily coronavirus cases and COVID-19-related deaths. Niedzielski said some 75% of COVID-19 hospital beds are taken.

The country of some 38 million people has administered almost 8 million doses of the Pfizer, Moderna and AstraZeneca vaccines.

___

MUMBAI — India’s worst-hit and richest state India’s worst-hit and richest state Maharashtra will impose stricter restrictions for 15 days on Wednesday in an effort to stem the surge of coronavirus infections that is threatening to overcome hospitals.

Top Maharashtra state officials stressed that the closure of most industries, businesses, public places and limits on the movement of people didn’t constitute a lockdown.

Last year, a sudden, harsh, nationwide lockdown left millions of people in India jobless overnight. Stranded in cities with no income or food, thousands of migrant workers walked on highways to get home. Since then, state leaders have repeatedly stressed that another lockdown wasn’t in the cards.

India on Wednesday reported over 180,000 new coronavirus cases in the past 24 hours, about a third in Maharashtra state, and a total of 13.9 million cases in the pandemic.

Maharashtra Chief Minister Uddhav Thackeray said that most public places, shops and establishments will be shut for 15 days starting 8 p.m. Wednesday, except for essential services like grocery stores and bank..

___

Featured Article: What is an economic bubble?



7 Things You Need To Know About Cryptocurrency

The Cryptocurrency Market Is About To Boil Over

The cryptocurrency was quiet for years, but it’s starting to boil over once again. With the price of Bitcoin up 550%, it certainly seems like the sky is the limit.

Whether or not you choose to trade Bitcoin or any other cryptocurrency, it is important to understand what it is and the trends driving it.

The bottom line, however, is that the world’s money is flowing onto the blockchain, and the use of cryptocurrency is growing at an exponential rate.

View the "7 Things You Need To Know About Cryptocurrency".


Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Johnson & Johnson (JNJ)2.5$168.50flat2.40%26.49Buy$185.70
Compare These Stocks  Add These Stocks to My Watchlist 

MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.